ContractClinical Trial Agreement This Agreement • April 29th, 2019
Contract Type FiledApril 29th, 2019CLINICAL TRIAL AGREEMENT THIS AGREEMENT (this“Agreement”) is made and entered into as of the date of disclosure in the Register of Contracts (the "Effective Date") by and between Immunomedics, Inc., a Delaware corporation having a place of business at 300 The American Road, Morris Plains, New Jersey 07950, tax ID: 61-1009366 (hereinafter "SPONSOR"), and Fakultní nemocnice Olomouc, with its registered office located at I.P. Pavlova 185/6, Nová Ulice, 779 00 Olomouc, IČO (Company ID): 00098892, VAT:CZ00098892, represented by Prof. Roman Havlik, M.D., Ph.D.(hereinafter “INSTITUTION”), RECITALS WHEREAS, SPONSOR conducts business in the research, development, and manufacture of biopharmaceutical products. WHEREAS, SPONSOR desires INSTITUTION to conduct a clinical trial and INSTITUTION desires to conduct same, said trial being entitled: Protocol: IMMU 132-06. A Phase II open label, study of IMMU-132 in metastatic urothelial cancer after failure of platinum-based regimen or anti-PD-1/ PD-L1 b